UNLEASHING THE POWER OF CLINICAL TRIALS FOR PATIENTS & UK LIFE SCIENCES
Bringing together industry, the NHS and academia to explore how clinical trials can drive innovation & improve patient outcomes.
date and time
Tuesday 31st October 2023, 16:00 – 18:15 followed by Reception
Molecular Science Research Hub (MSRH)
White City Innovation Disctrict, W12
82 Wood Ln, London W12 0BZ, [Map]
Jawdrop Fireside: Life Sciences follows this February’s successful inaugural Jawdrop Summit: Life Sciences in White City Innovation District (WCID).
WCID is fast emerging as a global economic hotspot in science, technology, engineering, mathematics, medicine and business (STEMMB).
Within this thriving deep-tech innovation ecosystem, there has been an incredible growth of Life Science businesses. A key factor for this attraction has been proximity to Imperial College London and Imperial Healthcare Trust, through which Life Science businesses can access Hammersmith Hospital, the North West London Clinical Trials Alliance and Paddington Life Sciences.
Jawdrop Fireside Life Sciences brings together industry leaders, NHS representatives, and academic experts to explore how the use of clinical trials can drive innovation and improve patient outcomes. In an increasingly competitive global environment, the number of industry clinical trials initiated in the UK per year fell by 41% between 2017 and 2021. This challenge is clearly recognised by Government, regulatory and professional bodies; the panel will debate the Government’s proposals on clinical trials, the importance of fostering collaboration between industry, the NHS, and academia as well as the ethical and regulatory considerations.
Opening: Dr June Raine DBE, CEO, Medicines and Healthcare products Regulatory Agency (MHRA)
Closing: Dr Suki Balendra, Imperial College Healthcare NHS Trust, Director of Strategic Partnerships at Paddington Life Sciences & Life sciences Lead for the NIHR CRN North West London
- Prof. Graham Cooke, Imperial College London, Vice Dean (Research) for the Faculty of Medicine (Chair)
- Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare NHS Trust
- Rob Hastings, Medical Affairs Director – Novartis UK
- Angela McFarlane, Vice President, Strategic Planning, Northern Europe, IQVIA
- Nahuel Villegas, CSO – Vivan Therapeutics